{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T22:07:05Z","timestamp":1790114825488,"version":"4.0.1"},"reference-count":27,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T00:00:00Z","timestamp":1776816000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The French Journal of Urology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.fjurol.2026.103125","type":"journal-article","created":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T16:16:45Z","timestamp":1776874605000},"page":"103125","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Real-life PI-RADS score and biochemical recurrence after local treatment of prostate cancer in Afro-Caribbean men"],"prefix":"10.1016","volume":"36","author":[{"given":"Yvanne","family":"Sadreux","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Kaulanjan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Laguerre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Mollard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles","family":"Gourtaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cedric","family":"Senechal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Blanchet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Brureau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.fjurol.2026.103125_bib0140","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"issue":"19","key":"10.1016\/j.fjurol.2026.103125_bib0145","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1056\/NEJMoa1801993","article-title":"MRI-targeted or standard biopsy for prostate-cancer diagnosis","volume":"378","author":"Kasivisvanathan","year":"2018","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.fjurol.2026.103125_bib0150","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.eururo.2015.08.052","article-title":"PI-RADS prostate imaging\u00a0\u2013\u00a0reporting and data system: 2015, version 2","volume":"69","author":"Weinreb","year":"2016","journal-title":"Eur Urol"},{"issue":"5","key":"10.1016\/j.fjurol.2026.103125_bib0155","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.purol.2023.01.004","article-title":"Direct comparison between Grade Group assessed on systematic and MRI\/ultrasound fusion targeted biopsies correlated to the radical prostatectomy specimens in patients with prostate cancer","volume":"33","author":"Payrard-Starck","year":"2023","journal-title":"Prog Urol"},{"issue":"1","key":"10.1016\/j.fjurol.2026.103125_bib0160","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S1470-2045(18)30569-2","article-title":"Use of prostate systematic and targeted biopsy on the basis of multiparametric MRI in biopsy-naive patients (MRI-FIRST): a prospective, multicentre, paired diagnostic study","volume":"20","author":"Rouvi\u00e8re","year":"2019","journal-title":"Lancet Oncol"},{"issue":"2","key":"10.1016\/j.fjurol.2026.103125_bib0165","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.eururo.2024.03.027","article-title":"EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer\u00a0\u2014\u00a02024 Update. Part I: screening, diagnosis, and local treatment with curative intent","volume":"86","author":"Cornford","year":"2024","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/j.fjurol.2026.103125_bib0170","doi-asserted-by":"crossref","DOI":"10.1177\/15579883251315099","article-title":"Variation in clinically significant prostate cancer on fusion biopsy of PI-RADS 3\u20135 lesions based on ethnicity","volume":"19","author":"Edelblute","year":"2025","journal-title":"Am J Mens Health"},{"issue":"3","key":"10.1016\/j.fjurol.2026.103125_bib0175","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1097\/JU.0000000000001810","article-title":"A comparison of image-guided targeted prostate biopsy outcomes by PI-RADS\u00ae score and ethnicity in a diverse, multiethnic population","volume":"206","author":"Hines","year":"2021","journal-title":"J Urol"},{"issue":"4","key":"10.1016\/j.fjurol.2026.103125_bib0180","first-page":"11955","article-title":"MRI-based PI-RADS score predicts ISUP upgrading and adverse pathology at radical prostatectomy in men with biopsy ISUP 1 prostate cancer","volume":"31","author":"Dekalo","year":"2024","journal-title":"Can J Urol"},{"issue":"3","key":"10.1016\/j.fjurol.2026.103125_bib0185","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1148\/radiol.2021202425","article-title":"Prognostic features of biochemical recurrence of prostate cancer following radical prostatectomy based on multiparametric MRI and immunohistochemistry analysis of MRI-guided biopsy specimens","volume":"299","author":"Harmon","year":"2021","journal-title":"Radiology"},{"issue":"5","key":"10.1016\/j.fjurol.2026.103125_bib0190","first-page":"193e7","article-title":"Radical prostatectomy findings and oncologic outcomes in patients with prostate cancer detected on systematic sextant biopsy only, MRI-targeted biopsy only, or both","volume":"40","author":"Suresh","year":"2022","journal-title":"Urol Oncol Semin Orig Investig"},{"issue":"2","key":"10.1016\/j.fjurol.2026.103125_bib0195","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.eururo.2021.07.027","article-title":"Risk stratification of patients candidate to radical prostatectomy based on clinical and multiparametric magnetic resonance imaging parameters: development and external validation of novel risk groups","volume":"81","author":"Mazzone","year":"2022","journal-title":"Eur Urol"},{"issue":"2","key":"10.1016\/j.fjurol.2026.103125_bib0200","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1158\/1055-9965.EPI-21-0697","article-title":"Contributions of social factors to disparities in prostate cancer risk profiles among black men and non-hispanic white men with prostate cancer in California","volume":"31","author":"Press","year":"2022","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"6","key":"10.1016\/j.fjurol.2026.103125_bib0205","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1097\/01.ju.0000158155.33890.e7","article-title":"The university of California, San Francisco cancer of the prostate risk assessment score: a straightforward and reliable preoperative predictor of disease recurrence after radical prostatectomy","volume":"173","author":"Cooperberg","year":"2005","journal-title":"J Urol"},{"issue":"3","key":"10.1016\/j.fjurol.2026.103125_bib0210","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/j.1464-410X.2012.11400.x","article-title":"Prognostic value of the CAPRA clinical prediction rule: a systematic review and meta-analysis","volume":"111","author":"Meurs","year":"2013","journal-title":"BJU Int"},{"issue":"5","key":"10.1016\/j.fjurol.2026.103125_bib0215","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1007\/s11255-013-0495-y","article-title":"Predictors of Gleason score upgrading in a large African-American population","volume":"45","author":"Vora","year":"2013","journal-title":"Int Urol Nephrol"},{"issue":"3","key":"10.1016\/j.fjurol.2026.103125_bib0220","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1097\/01.ju.0000134888.22332.bb","article-title":"Cancer progression and survival rates following anatomical radical retropubic prostatectomy in 3478 consecutive patients: long-term results","volume":"172","author":"Roehl","year":"2004","journal-title":"J Urol"},{"issue":"5","key":"10.1016\/j.fjurol.2026.103125_bib0225","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/j.juro.2017.10.042","article-title":"Pathological and 3 tesla volumetric magnetic resonance imaging predictors of biochemical recurrence after robotic assisted radical prostatectomy: correlation with whole mount histopathology","volume":"199","author":"Tan","year":"2018","journal-title":"J Urol"},{"issue":"2","key":"10.1016\/j.fjurol.2026.103125_bib0230","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/s41391-023-00712-z","article-title":"Biochemical recurrence in patients with prostate cancer after primary definitive therapy: treatment based on risk stratification","volume":"27","author":"Shore","year":"2024","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"2","key":"10.1016\/j.fjurol.2026.103125_bib0235","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/s41391-023-00727-6","article-title":"Model risk scores may underestimate rate of biochemical recurrence in African American men with localized prostate cancer: a cohort analysis of over 3000 men","volume":"27","author":"Epstein","year":"2024","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"5","key":"10.1016\/j.fjurol.2026.103125_bib0240","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/S0360-3016(99)00321-1","article-title":"The impact of race on biochemical disease-free survival in early-stage prostate cancer patients treated with surgery or radiation therapy","volume":"45","author":"Hart","year":"1999","journal-title":"Int J Radiat Oncol"},{"issue":"8\u20139","key":"10.1016\/j.fjurol.2026.103125_bib0245","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.purol.2018.03.015","article-title":"Predictors of biochemical recurrence after radical prostatectomy in an Afro-Caribbean population in Guadeloupe (French West Indies)","volume":"28","author":"Brureau","year":"2018","journal-title":"Prog Urol"},{"issue":"9","key":"10.1016\/j.fjurol.2026.103125_bib0250","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1002\/cncr.33419","article-title":"Oncologic outcomes among black and white men with grade group 4 or 5 (Gleason score 8\u201310) prostate cancer treated primarily by radical prostatectomy","volume":"127","author":"Wilkins","year":"2021","journal-title":"Cancer"},{"issue":"4b","key":"10.1016\/j.fjurol.2026.103125_bib0255","first-page":"E186","article-title":"Pathological outcome and biochemical recurrence-free survival after radical prostatectomy in African-American, Afro-Caribbean (Jamaican) and Caucasian-American men: an international comparison","volume":"111","author":"Ritch","year":"2013","journal-title":"BJU Int [Internet]"},{"issue":"5","key":"10.1016\/j.fjurol.2026.103125_bib0260","doi-asserted-by":"crossref","first-page":"e1060","DOI":"10.1016\/j.clgc.2019.06.008","article-title":"Variation in positive surgical margin status after radical prostatectomy for pT2 prostate cancer","volume":"17","author":"Tan","year":"2019","journal-title":"Clin Genitourin Cancer"},{"issue":"6","key":"10.1016\/j.fjurol.2026.103125_bib0265","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.euo.2020.07.008","article-title":"Prognostic implications of multiparametric magnetic resonance imaging and concomitant systematic biopsy in predicting biochemical recurrence after radical prostatectomy in prostate cancer patients diagnosed with magnetic resonance imaging\u2013targeted biopsy","volume":"3","author":"Gandaglia","year":"2020","journal-title":"Eur Urol Oncol"},{"issue":"6","key":"10.1016\/j.fjurol.2026.103125_bib0270","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1002\/pros.24490","article-title":"Risk stratification for early biochemical recurrence of prostate cancer in the era of multiparametric magnetic resonance imagining-targeted biopsy","volume":"83","author":"Diamand","year":"2023","journal-title":"Prostate"}],"container-title":["The French Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950393026000562?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950393026000562?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T21:35:18Z","timestamp":1790112918000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2950393026000562"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":27,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S2950393026000562"],"URL":"https:\/\/doi.org\/10.1016\/j.fjurol.2026.103125","relation":{},"ISSN":["2950-3930"],"issn-type":[{"value":"2950-3930","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Real-life PI-RADS score and biochemical recurrence after local treatment of prostate cancer in Afro-Caribbean men","name":"articletitle","label":"Article Title"},{"value":"The French Journal of Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fjurol.2026.103125","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"103125"}}